Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype. - Wikidata - awgldk - TriplyDB

Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype.

Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype.

http://www.wikidata.org/entity/Q35871717

about

Cancer stem cells (CSCs), cervical CSCs and targeted therapies Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardium Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence"Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression Comparison of cancer stem cell antigen expression by tumor cell lines and by tumor biopsies from dogs with melanoma and osteosarcoma Gain of HIF-1α under normoxia in cancer mediates immune adaptation through the AKT/ERK and VEGFA axes.MC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer model Nanog signaling in cancer promotes stem-like phenotype and immune evasion Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.Targeting cancer stem cells: emerging role of Nanog transcription factor In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.API5 confers cancer stem cell-like properties through the FGF2-NANOG axis.Ino80 promotes cervical cancer tumorigenesis by activating Nanog expression.Preclinical vaccines against mammary carcinoma.Cancer stem cells converted from pluripotent stem cells and the cancerous niche.Stem cell transcription factor NANOG in cancers--is eternal youth a curse?Cancer Stem Cells: Dynamic Entities in an Ever-Evolving Paradigm.Photodynamic therapy-mediated cancer vaccination enhances stem-like phenotype and immune escape, which can be blocked by thrombospondin-1 signaling through CD47 receptor protein.NANOG signaling promotes metastatic capability of immunoedited tumor cells.Immune-mediated tumor evolution: Nanog links the emergence of a stem like cancer cell state and immune evasion.A comparative transcriptomic analysis reveals conserved features of stem cell pluripotency in planarians and mammals.NANOG as an adverse predictive marker in advanced non-small cell lung cancer treated with platinum-based chemotherapy.API5 induces cisplatin resistance through FGFR signaling in human cancer cells.Cancer stem cells as targets for immunotherapy.Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.

P2860

Q26747144-96163F04-0D1F-4429-829E-B3A32B3DD935 Q28088370-0EA7BCFD-315E-426C-8000-EB8D2234EF01 Q28305306-172A5706-92BB-419F-93A8-5FE22C793607 Q28391909-F6EBA520-0A65-4DE3-8200-6805B2841221 Q28540510-FCB11957-4ED4-436D-967E-8AB4E5752CE6 Q33816240-A1B870E4-6997-456F-88CE-EF6735B81650 Q34688250-758A2BA7-EDD2-40D5-B4E2-18CD1109B8F3 Q35178345-D1B84481-2CC4-488D-84FD-2BCD00CB8488 Q36256568-F6259625-3B63-499B-AF6C-DE94C02981BC Q36357895-26712C1B-2087-43D4-95F9-3DA01401EAEC Q36905769-D4C0731B-1547-4364-A95F-D71DB2C4181F Q37170030-DD047B41-F68F-4B10-B853-939A662C7125 Q37344789-4CF1C654-E696-40E0-97B6-9B3BD08537FA Q37627441-717191B0-C1BE-4505-B976-D8AF7E6FB9C0 Q37687811-6067292A-CC8C-421A-85E0-425E23AA0E33 Q38160252-64A8AFDF-93B6-48CF-925C-F6CEB2792200 Q38235250-8928AA4C-E0DB-4A1A-BDAF-A2AAE9FDEF07 Q38658623-384B5862-31ED-453C-A303-48D08E59A692 Q38829440-03ACE838-D4CE-47F4-87E5-1A66D9A5B550 Q40403603-DDE2E96B-5F1D-4EA1-9CAB-AF6CA19E6FEF Q41300653-95AAD95A-B544-4126-8E70-AA05AED6E52F Q41528708-ECFEF711-C571-4417-8059-A960A3118AA4 Q41829171-189C83BC-3ADA-4069-87F1-B150657134DA Q42364472-B7EA4317-6246-49BB-96F3-E7DBE2D211D0 Q42370427-E5506578-92B3-4C79-B005-76EBB3863DFB Q48278683-3857C86E-D2C5-436A-91D5-D5491D12F3BF Q55424304-0B4AEEDF-DF07-4DA6-AB01-609D227E8DD1

P2860

Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype.

http://www.wikidata.org/entity/Q35871717

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Cancer vaccination drives Nano ...... stant and stem-like phenotype.

@ast

Cancer vaccination drives Nano ...... stant and stem-like phenotype.

@en

type

label

Cancer vaccination drives Nano ...... stant and stem-like phenotype.

@ast

Cancer vaccination drives Nano ...... stant and stem-like phenotype.

@en

prefLabel

Cancer vaccination drives Nano ...... stant and stem-like phenotype.

@ast

Cancer vaccination drives Nano ...... stant and stem-like phenotype.

@en

P1433

Q35871717-3600F22C-1F0E-4FCE-8A0F-72D5925298B7

P1476

Q35871717-A34EEAD5-336D-4DC2-8BAF-47216F07C526

P2093

Q35871717-43587CF3-3F42-4A35-99FD-E56F2E908AA9

Q35871717-701F1592-08E0-45BA-901C-FD19DB8BD5AB

Q35871717-9CFCE72A-0BDB-4F16-BCF6-CDB18E1E7D25

Q35871717-9ECD5E4A-7C5E-4F11-A003-F4D8C12D0BAD

Q35871717-A672F836-01FE-464B-A345-A48DAE2373B6

Q35871717-D492F2E0-904D-4047-BC18-1A627B56FF2D

Q35871717-E8A67CED-A4CB-4D99-9553-DC9C48921A2C

P2860

Q35871717-0497087F-9411-4EA4-B4D6-A7FFAAA99894

Q35871717-08F801C1-5AFF-466D-AB3A-EE64E1D65136

Q35871717-0FBD93A7-6D8F-445C-8AD6-68D180AA63DC

Q35871717-19A4B124-B32D-41F4-BCCF-3A2F075046E6

Q35871717-19D90709-788D-4EBA-9738-FA4399B2F5FA

Q35871717-1CDBD45A-50B8-49D2-B405-B824EECE4E80

Q35871717-39696C87-147D-43BB-91EF-09B660DEA388

Q35871717-4680151F-FA15-4253-95B9-880B5686FD90

Q35871717-4DB9EF04-9B68-410E-A8C6-D4A02F5367C6

Q35871717-4F003308-D53C-41C4-BD7D-E9C8A2D57F2F

P304

Q35871717-19929233-AE6C-4F56-A568-64DBEA22C4E2

P31

Q35871717-A2F21434-10EA-4EA3-A471-F59F5C96A976

P356

Q35871717-F222D42D-5B15-4EFA-92CD-AE30679604E1

P407

Q35871717-14668373-201A-438D-B0D2-7C7C72151EF3

P433

Q35871717-A823A7F3-BA68-42AA-BBAE-16A6ADA4764F

P478

Q35871717-CD0202BB-BE34-4150-AD76-03EA2228B8EC

P577

Q35871717-D3849EE1-B548-4B6A-8CF2-E8E8B1A7B0AB

P698

Q35871717-408F52D2-6FC8-4149-8E4F-3637B23D621B

P932

Q35871717-6B2B524F-6DE5-4543-90B8-7B6CF3BA08DF

P356

0008-5472.CAN-11-3758

P1433

Cancer Research

P1476

Cancer vaccination drives Nano ...... stant and stem-like phenotype.

@en

P2093

Chih-Ping Mao

http://www.w3.org/2001/XMLSchema#string

Ju-Hong Jeon

http://www.w3.org/2001/XMLSchema#string

Kyung Hee Noh

http://www.w3.org/2001/XMLSchema#string

T-C Wu

http://www.w3.org/2001/XMLSchema#string

Tae Heung Kang

http://www.w3.org/2001/XMLSchema#string

Tae Woo Kim

http://www.w3.org/2001/XMLSchema#string

Young-Ho Lee

http://www.w3.org/2001/XMLSchema#string

P2860

The role of vascular cell adhesion molecule-1 in tumor immune evasion

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Cancer immunoediting: from immunosurveillance to tumor escape

Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Tumour stem cells and drug resistance

Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties.

P304

1717-1727

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-11-3758

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22337995

http://www.w3.org/2001/XMLSchema#string

P932

3319841

http://www.w3.org/2001/XMLSchema#string